257.65
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Ecolab Inc stock is traded at $257.65, with a volume of 1.12M.
It is up +0.81% in the last 24 hours and down -2.51% over the past month.
Ecolab produces and markets cleaning and sanitation products for the industrial manufacturing, data center, hospitality, healthcare, and life sciences markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. Additionally, Ecolab sells customized water management and cooling solutions across its end markets. The company has a strong hold on the US market and is growing its presence abroad.
See More
Previous Close:
$255.59
Open:
$256.93
24h Volume:
1.12M
Relative Volume:
0.76
Market Cap:
$72.77B
Revenue:
$16.08B
Net Income/Loss:
$2.09B
P/E Ratio:
35.38
EPS:
7.2815
Net Cash Flow:
$1.90B
1W Performance:
-3.49%
1M Performance:
-2.51%
6M Performance:
-0.49%
1Y Performance:
+1.00%
Ecolab Inc Stock (ECL) Company Profile
Name
Ecolab Inc
Sector
Industry
Phone
18002326522
Address
1 ECOLAB PLACE, SAINT PAUL, MN
Compare ECL vs LIN, SHW, APD, SQM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ECL
Ecolab Inc
|
257.65 | 72.18B | 16.08B | 2.09B | 1.90B | 7.2815 |
|
LIN
Linde plc Ordinary Share
|
500.29 | 228.19B | 34.66B | 7.25B | 5.10B | 15.07 |
|
SHW
Sherwin Williams Co
|
312.46 | 76.58B | 23.94B | 2.60B | 2.91B | 10.42 |
|
APD
Air Products Chemicals Inc
|
303.93 | 66.44B | 12.46B | 2.16B | -1.25B | 9.454 |
|
SQM
Sociedad Quimica Y Minera De Chile Sa Adr
|
92.64 | 25.64B | 4.58B | 641.12M | 437.00M | 2.0592 |
Ecolab Inc Stock (ECL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-20-26 | Upgrade | Deutsche Bank | Hold → Buy |
| Mar-24-26 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-16-26 | Upgrade | Berenberg | Hold → Buy |
| Jan-23-26 | Downgrade | Erste Group | Buy → Hold |
| Nov-03-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-14-25 | Initiated | Erste Group | Buy |
| Aug-26-25 | Resumed | Raymond James | Mkt Perform |
| Jul-30-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Apr-21-25 | Upgrade | Seaport Research Partners | Neutral → Buy |
| Apr-16-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Mar-24-25 | Downgrade | Redburn Atlantic | Buy → Neutral |
| Jan-28-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-17-24 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Nov-04-24 | Downgrade | UBS | Buy → Neutral |
| Oct-18-24 | Upgrade | Jefferies | Hold → Buy |
| Aug-13-24 | Initiated | Wells Fargo | Overweight |
| Jul-31-24 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-31-24 | Upgrade | Citigroup | Neutral → Buy |
| Jul-08-24 | Upgrade | Stifel | Hold → Buy |
| Apr-12-24 | Upgrade | Mizuho | Neutral → Buy |
| Apr-03-24 | Initiated | Piper Sandler | Overweight |
| Mar-01-24 | Initiated | Wolfe Research | Peer Perform |
| Feb-28-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Feb-14-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-16-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-08-24 | Downgrade | Seaport Research Partners | Buy → Neutral |
| Nov-30-23 | Initiated | Raymond James | Outperform |
| Sep-01-23 | Initiated | Berenberg | Hold |
| Jul-05-23 | Downgrade | Northcoast | Buy → Neutral |
| Jun-14-23 | Initiated | Citigroup | Neutral |
| Apr-17-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-15-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Dec-02-22 | Downgrade | Barclays | Overweight → Equal Weight |
| Nov-02-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-13-22 | Upgrade | Seaport Research Partners | Neutral → Buy |
| Sep-06-22 | Upgrade | Northcoast | Neutral → Buy |
| Jul-15-22 | Initiated | Northcoast | Neutral |
| Jul-13-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-13-22 | Initiated | Wells Fargo | Overweight |
| Jun-03-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jun-02-22 | Upgrade | UBS | Neutral → Buy |
| May-20-22 | Resumed | Credit Suisse | Neutral |
| Apr-27-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-05-22 | Initiated | Atlantic Equities | Overweight |
| Mar-22-22 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-17-22 | Upgrade | Edward Jones | Hold → Buy |
| Feb-16-22 | Upgrade | JP Morgan | Underweight → Neutral |
| Feb-15-22 | Downgrade | Boenning & Scattergood | Outperform → Neutral |
| Jan-21-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-03-21 | Resumed | Evercore ISI | In-line |
| Oct-27-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-13-21 | Initiated | Mizuho | Neutral |
| Sep-27-21 | Initiated | Vertical Research | Hold |
| Sep-03-21 | Resumed | RBC Capital Mkts | Outperform |
| Aug-16-21 | Downgrade | Evercore ISI | Outperform → In-line |
| Apr-28-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Mar-30-21 | Upgrade | Deutsche Bank | Hold → Buy |
| Mar-29-21 | Resumed | Credit Suisse | Neutral |
| Mar-15-21 | Resumed | Credit Suisse | Neutral |
| Jan-15-21 | Upgrade | Gabelli & Co | Hold → Buy |
| Sep-22-20 | Initiated | Evercore ISI | Outperform |
| Jul-28-20 | Upgrade | Boenning & Scattergood | Neutral → Outperform |
| Jul-08-20 | Resumed | BofA Securities | Neutral |
| Jun-03-20 | Downgrade | Gabelli & Co | Buy → Hold |
| Mar-17-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Feb-07-20 | Downgrade | Boenning & Scattergood | Outperform → Neutral |
| May-01-19 | Reiterated | BofA/Merrill | Buy |
| Apr-18-19 | Downgrade | UBS | Buy → Neutral |
| Feb-20-19 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-31-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-23-18 | Resumed | BofA/Merrill | Buy |
| Jun-22-18 | Downgrade | JP Morgan | Neutral → Underweight |
| May-02-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-24-18 | Reiterated | Stifel | Hold |
| Jan-05-18 | Downgrade | Citigroup | Buy → Neutral |
| Nov-07-17 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-12-17 | Reiterated | RBC Capital Mkts | Outperform |
| Aug-15-17 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-02-17 | Reiterated | UBS | Buy |
| May-26-17 | Upgrade | JP Morgan | Neutral → Overweight |
View All
Ecolab Inc Stock (ECL) Latest News
Director David MacLennan adds Ecolab (ECL) shares in $256.912 open-market buy - Stock Titan
Commercial Fountain Filter Ecolab Ecotemp 12 ManualCowboyfasr 20k Gallon Carbon Block Filter - portalcantagalo.com.br
Ecolab Inc. stock outperforms competitors despite losses on the day - MarketWatch
Is It Too Late To Consider Ecolab (ECL) After CoolIT Deal And Rich P/E Multiple? - Yahoo Finance
Ecolab (ECL) Valuation Check After Recent Share Price Weakness - simplywall.st
Danske Bank A S Buys 20,247 Shares of Ecolab Inc. $ECL - MarketBeat
Caisse Des Depots ET Consignations Sells 4,693 Shares of Ecolab Inc. $ECL - MarketBeat
Raymond James Reaffirms Their Hold Rating on Ecolab (ECL) - The Globe and Mail
How Investors May Respond To Ecolab (ECL) Strong Q1 Results And New Korea Bioprocessing Lab - Yahoo Finance
Ecolab Life Sciences Opens Bioprocessing Applications Lab In Korea To Support Downstream Process Development Across Asia - Bioprocess Online
ECL Stock Price, Quote & Chart | ECOLAB INC (NYSE:ECL) - ChartMill
How Investors May Respond To Ecolab (ECL) Boosting 2026 Outlook And Expanding Digital Water Solutions - simplywall.st
Here's why you should retain Ecolab stock in your portfolio now - MSN
Bank of America Cuts Ecolab (ECL) Price Target, Maintains Buy on Long-Term Outlook - Insider Monkey
Ecolab Inc. stock outperforms competitors on strong trading day - MarketWatch
Ecolab slips after in-line Q1; Q2 earnings guidance mostly below consensus - MSN
11 AI Data Center Cooling Stocks to Own After the Ecolab-CoolIT Deal - MarketWise
Ecolab Life Sciences expands global bioprocessing capabilities with new centre in Korea - BioSpectrum Asia
Ecolab Inc. $ECL Stock Position Lessened by Mcdonald Capital Investors Inc. CA - MarketBeat
US Bancorp DE Grows Position in Ecolab Inc. $ECL - MarketBeat
Ecolab Life Sciences Opens Bioprocessing Applications Lab in Korea to Support Downstream Process Development Across Asia - CHEManager
Global Cold-Chain Friendly Post-Harvest Sanitizing Mist Market Outlook 2036: Growth Trends Led by AgroFresh, Ecolab, and Evonik - Morningstar
BMO Capital Reaffirms Their Buy Rating on Ecolab (ECL) - The Globe and Mail
Bioprocessing Applications Laboratory Opened in Korea by Ecolab Life Sciences - Genetic Engineering and Biotechnology News
Mitsubishi UFJ Trust & Banking Corp Decreases Stock Position in Ecolab Inc. $ECL - MarketBeat
Ecolab Inc. Stock (US2824031014): Dividend Hike Signals Steady Shareholder Returns - AD HOC NEWS
Ecolab Life Sciences opens bioprocessing applications lab in Korea to support downstream process development across Asia - Manufacturing Chemist
Ecolab Inc (ECL) Shares Fall 3.9% -- GF Value Says Still Overval - GuruFocus
Vanguard Capital Management owns 19.0M Ecolab shares (ECL) — 6.72% - Stock Titan
Ecolab to Webcast Annual Meeting on May 7, 2026 - marketscreener.com
Ecolab shifts 2026 annual meeting online, opens public webcast May 7 - Stock Titan
Ecolab Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
A Quick Look at Today's Ratings for Ecolab(ECL.US), With a Forecast Between $290 to $345 - Moomoo
Ecolab Opens Bioprocessing Applications Lab in Korea, Its First Bioprocessing Facility in Asia - Contract Pharma
Ecolab Reports Strong Earnings Growth - Chemical Industry Digest
Analysts Offer Insights on Materials Companies: Ecolab (ECL) and Boise Cascade (BCC) - The Globe and Mail
Citigroup Adjusts Price Target on Ecolab to $325 From $330, Maintains Buy Rating - marketscreener.com
Baird Adjusts Price Target on Ecolab to $290 From $296, Maintains Outperform Rating - marketscreener.com
Ecolab invests heavily in talent growth amid competitive promotions - MSN
Ecolab Inc. (NYSE:ECL) Q1 2026 Earnings Call Transcript - Insider Monkey
New Korea lab helps Asian drugmakers avoid overseas transfers - Stock Titan
Comerica Bank Trims Stock Position in Ecolab Inc. $ECL - MarketBeat
Research Alert: CFRA Maintains Buy Opinion On Shares Of Ecolab Inc. - Moomoo
Corrosion Inhibitors Market: Asia Leads Growth as Ecolab, BASF, Nouryon Drive 2036 Outlook - openPR.com
Ecolab Inc (ECL) Q1 2026 Earnings Call Highlights: Strong Growth Amidst Challenges By GuruFocus - Investing.com Canada
Ecolab Inc (ECL) Q1 2026 Earnings Call Highlights: Strong Growth Amidst Challenges - GuruFocus
Ecolab Q1 2026: Revenue Hits $4.07B, Up 10% Year-Over-Year - AlphaStreet
Ecolab Earnings Call Highlights Growth, Margin Momentum - TipRanks
Ecolab Poised for Long-Term Growth as Strong Customer Switching Costs Drive Pricing Power - Morningstar
Ecolab (ECL) Margin Slippage Puts Bullish Efficiency Narrative To The Test - simplywall.st
US278865BF65 Bond Risk Analysis - TradingView
Ecolab Inc Stock (ECL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):